Bold Vision.
Innovation at its best.

ProPhase Labs is a next-generation biotech, genomics and diagnostics company. Our goal is to create a healthier world with bold action and the power of insight. We’re revolutionizing healthcare with industry-leading Whole Genome Sequencing solutions, while developing potential game changer diagnostics and therapeutics in the fight against cancer. This includes a potentially life-saving cancer test focused on early detection of esophageal cancer and potential breakthrough cancer therapeutics with novel mechanisms of action. Our world-class CLIA labs and cutting-edge diagnostic technology provide wellness solutions for healthcare providers and consumers.

We develop, manufacture, and commercialize health and wellness solutions to enable people to live their best lives.  We are committed to executional excellence, smart diversification, and a synergistic, omni-channel approach.







Press Releases

See our latest innovations and breaking news

Nov 09 2023 8:00AM ET

ProPhase Labs Announces Financial Results for the Three Months Ended September 30, 2023

Read More

Nov 02 2023 8:00AM ET

ProPhase Labs to Host Third Quarter 2023 Financial Results Conference Call on Thursday, November 9, 2023 at 11:00 a.m. Eastern Time

Read More

Oct 17 2023 8:00AM ET

ProPhase Labs Announces Substantial Growth Expectations for Pharmaloz Manufacturing Subsidiary due to Skyrocketing Demand for Pharmaloz Output.

Read More
Investor Relations

Get In Touch

We care about your questions and will be in touch usually within 24 hours

"*" indicates required fields

This field is for validation purposes and should be left unchanged.
Dev Tool:

Request: None
Matched Rewrite Rule: None
Matched Rewrite Query: None
Loaded Template: front-page.php